Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series.
Acta Derm Venereol
; 100(1): adv00014, 2020 Jan 07.
Article
in En
| MEDLINE
| ID: mdl-31709451
Full text:
1
Database:
MEDLINE
Main subject:
Skin
/
Dermatitis, Atopic
/
Dermatologic Agents
/
Antibodies, Monoclonal, Humanized
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Female
/
Humans
/
Male
Language:
En
Year:
2020
Type:
Article